An evaluation of the inhibition of human butyrylcholinesterase and acetylcholinesterase by the organophosphate chlorpyrifos oxon

Toxicology and Applied Pharmacology

Volumn 241, Issue 2, 2009, Pages 135-142

  Shenouda, Josephine ^a   Green, Paula ^a   Sultatos, Lester ^b  

^a University of Medicine and Dentistry of New Jersey   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Acetylcholinesterase; Butyrylcholinesterase; Chlorpyrifos oxon; Organophosphate insecticides; Pesticides

Indexed keywords

ACETYLCHOLINESTERASE; BUTYRYLTHIOCHOLINE; CHLORPYRIFOS; CHLORPYRIFOS OXON; CHOLINESTERASE; UNCLASSIFIED DRUG;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVE SITE; ENZYME INHIBITION; ENZYME KINETICS; MICHAELIS MENTEN KINETICS;

ACETYLCHOLINESTERASE; ACETYLTHIOCHOLINE; BUTYRYLCHOLINESTERASE; BUTYRYLTHIOCHOLINE; CHLORPYRIFOS; CHOLINESTERASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; KINETICS;

EID: 70350234489     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2009.08.014     Document Type: Article

References (45)

1. Alles G.A., and Hawes R.C. Cholinesterases in the blood of man. J. Biol. Chem. 133 (1940) 375-390
2. Amitai G., Moorad D., Adani R., and Doctor B.P. Inhibition of acetylcholinesterase and butyrylcholinesterase by chlorpyrifos oxon. Biochem. Pharmacol. 56 (1998) 293-299
3. Badiou A., Froment M.T., Fournier D., Masson P., and Belzunces L.P. Hysteresis of insect acetylcholinesterase. Chem.-Biol. Interact. 175 (2008) 410-412
4. Barak D., Ordentlich A., Bromber A., Kronman C., Marcus D., Lazar A., Ariel N., Velan B., Shafferman A., Ariel N., Velan B., and Shafferman A. Allosteric modulation of acetylcholinesterase activity by peripheral ligands involves a conformational transition of the anionic subsite. Biochemistry 34 (1995) 15444-15452
5. Bourne Y., Taylor P., Radic Z., and Marchot P. Structural insights into ligand interactions at the acetylcholinesterase peripheral anionic site. EMBO J. 22 (2003) 1-12
6. Cellier F.E. Continuous System Modeling (1991), Springer-Verlag, New York
7. Colletier J.P., Fournier D., Greenblatt H.M., Stojan J., Sussman J.L., Zaccai G., Silman I., and Weik M. Structural insights into substrate traffic and inhibition in acetylcholinesterase. EMBO J. 25 (2006) 2746-2756
8. Darvesh S., Hopkins D.A., and Geula C. Neurobiology of butyrylcholinesterase. Annu. Rev. Neurosci. 4 (2003) 131-138
9. Ellman G.L., Courtney D., Valention A., and Featherstone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7 (1961) 88-95
10. Gray P.J., and Duggleby R.G. Analysis of kinetic data for irreversible enzyme inhibition. Biochem. J. 257 (1989) 419-424
11. Harel M., Sussman J.L., Krejci E., Bon S., Chanal P., Massoulié J., and Silman I. Conversion of acetylcholinesterase to butyrylcholinesterase. Modeling and mutagenesis. Proc. Natl. Acad. Sci. 89 (1992) 10827-10831
12. Hart G.J., and O'Brien R.D. Recording spectrophotometric method for determination of dissociation and phosphorylation constants for the inhibition of acetylcholinesterase by organophosphates in the presence of substrate. Biochemistry 12 (1973) 2940-2945
13. James L.C., and Tawfik D.S. Conformational diversity and protein evolution-a 60-year-old hypothesis revisited. Trends Biochem. Sci. 28 (2003) 361-368
14. Johnson J.L., Cusack B., Davies M.P., Fauq A., and Rosenberry T.L. Unmasking tandem site interaction in human acetylcholinesterase. Substrate activation with a cationic acetanilide substrate. Biochemistry 42 (2003) 5438-5452
15. Kaushik R., Rosenfeld C.A., and Sultatos L.G. Concentration-dependent interactions of the organophosphates chlorpyrifos oxon and methyl paraoxon with human recombinant acetylcholinesterase. Toxicol. Appl. Pharmacol. 221 (2007) 243-250
16. Levitsky V., Xie W., Froment M.-T., Lockridge O., and Masson P. Polyol-induced activation by excess substrate of the D70G butyrylcholinesterase mutant. Biochim. Biophys. Acta 1429 (1999) 422-430
17. Lin W., and Tsou C.L. Determination of rate constants for the irreversible inhibition of acetylcholine esterase by continuously monitoring the substrate reaction in the presence of the inhibitor. Biochim. Biophys. Acta 870 (1986) 185-190
18. Lockridge O., Bartels C.F., Vaughan T.A., Wong C.K., Norton S.E., and Johnson I.I. Complete amino acid sequence of human serum cholinesterase. J. Biol. Chem. 262 (1987) 549-557
19. Main A.R. Affinity and phosphorylation constants for the inhibition of esterases by organophosphates. Science 144 (1964) 992-993
20. Marcel V.S., Estrada-Mondaca S., Magne F., Stojan J., Kleebe A., and Fournier D. Exploration of the Drosophila acetylcholinesterase substrate activation site using a reversible inhibitor (Triton X-100) and mutated unzymes. J. Biol. Chem. 275 (2000) 11603-11609
21. Masson P., Froment M.-T., Bartels C.F., and Lockridge O. Asp70 in the peripheral anionic site of human butyrylcholinesterase. Eur. J. Biochem. 235 (1996) 36-48
22. Masson P., Legrand P., Bartels C.F., Froment M.-T., Schopfer L.M., and Lockridge O. Role of aspartate 70 and tryptophan 82 in binding of succinyldithiocholine to human butyrylcholinesterase. Biochemistry 36 (1997) 2266-2277
23. Masson P., Xie W., Froment M.-T., and Lockridge O. Effects of mutations of active site residues and amino acids interacting with the Ω loop on substrate activation of butyrylcholinesterase. Biochim. Biophys. Acta 1544 (2001) 166-176
24. Masson P., Schopfer L.M., Bartels C.F., Froment M.-T., Ribes F., Nachon F., and Lockridge O. Substrate activation in acetylcholinesterase induced by low pH or mutation in the π-cation subsite. Biochim. Biophys. Acta 1594 (2002) 313-324
25. Masson P., Nachon F., Bartels C.F., Froment M.-T., Ribes F., Mathews C., and Lockridge O. High activity of human butyrylcholinesterase at low pH in the presence of excess butyrylthiocholine. Eur. J. Biochem. 270 (2003) 315-324
26. Masson P., Schopfer L.M., Froment M.-T., Debouzy J.-C., Nachon F., Gillon E., Lockridge O., Hrabovska A., and Goldstein B.N. Hysteresis of butyrylcholinesterase in the approach to steady-state kinetics. Chem.-Biol. Interact. 157-158 (2005) 143-152
27. Masson P., Froment M.-T., Gillon E., Nachon F., Darvesh S., and Schopfer L.M. Kinetic analysis of butyrylcholinesterase-catalyzed hydrolysis of acetanilides. Biochim. Biophys. Acta 1774 (2007) 1139-1147
28. Masson P., Froment M.-T., Gillon E., Nachon F., Lockridge O., and Schopfer L.M. Kinetic analysis of effector modulation of butyrylcholinesterase-catalyzed hydrolysis of acetanilides and homologous esters. FEBS J. 275 (2008) 2617-2631
29. Nicolet Y., Lockridge O., Masson P., Fontecill-Camps J.C., and Nachon F. Crystal structure of human butyrylcholinesterase and of its complexes with substrates and products. J. Biol. Chem. 278 (2003) 41141-41147
30. Ordentlich A., Barak D., Kronman C., Flashner Y., Leitner M., Segall Y., Ariel N., Cohen S., Velan B., and Shafferman A. Dissection of the human acetylcholinesterase active center determinants of substrate specificity. Identification of residues constituting the anionic site, the hydrophobic site, and the acyl pocket. J. Biol. Chem. 268 (1993) 17083-17095
31. Quinn D.M. Acetylcholinesterase: Enzyme structure, reaction dynamics and virtual transition states. Chem. Rev. 87 (1987) 955-979
32. Radić Z., Pickering N.A., Vellom D.C., Camp S., and Taylor P. Three distinct domains in the cholinesterase molecule confer selectivity for acetyl- and butyrylcholinesterase inhibitors. Biochemistry 32 (1993) 12074-12084
33. Reiner E., and Simeon-Rudolf V. Cholinesterase: substrate inhibition and substrate activation. Pflügers Arch. - Eur. J. Physiol. 440 (Suppl.) (2000) R118-R120
34. Rosenberry T.L., Mallender W.D., Thomas P.J., and Szegletes T. A steric blockade model for inhibition of acetylcholinesterase by peripheral site ligands and substrate. Chem. Biol. Interact. 119-120 (1999) 85-97
35. Rosenfeld C.A., and Sultatos L.G. Concentration-dependent kinetics of acetylcholinesterase inhibition by the organophosphate paraoxon. Toxicol. Sci. 90 (2006) 460-469
36. Saxena A., Redman A.M.G., Jiang X., Lockridge O., and Doctor B.P. Differences in active-site gorge dimensions of cholinesterases revealed by binding of inhibitors to human butyrylcholinesterase. Chem. Biol. Interact 119-120 (1999) 61-69
37. Shafferman A., Velan B., Ordentlich A., Kronman C., Grosfeld H., Leitner M., Flashner Y., Cohen S., Barak D., and Ariel N. Substrate inhibition of acetylcholinesterase: residues affecting signal transduction from the surface to the catalytic center. EMBO J. 11 (1992) 3561-3568
38. Stojan J., and Pavlič M.R. Velocity of Ellman's reaction and its implication for kinetic studies in the millisecond time range. Neurochem. Res. 17 (1992) 1207-1210
39. Stojan J., Goličnik M., Froment M.-T., Estour F., and Masson P. Concentration-dependent reversible activation-inhibition of human butyrylcholinesterase by tetraethylammonium ion. Eur. J. Biochem. 269 (2002) 1154-1161
40. Stojan J., Brochier L., Alies C., Colletier J.P., and Fournier D. Inhibition of Drosophila melanogaster acetylcholinesterase by high concentrations of substrate. Eur. J. Biochem. 271 (2004) 1364-1371
41. Sultatos L.G. Concentration-dependent binding of chlorpyrifos oxon to acetylcholinesterase. Toxicol. Sci. 100 (2007) 128-135
42. Sultatos L.G., and Kaushik R. Altered binding of thioflavin t to the peripheral anionic site of acetylcholinesterase after phosphorylation of the active site by chlorpyrifos oxon or dichlorvos. Toxicol. Appl. Pharmacol. 230 (2008) 390-396
43. Taylor J.R. An introduction to error analyses: the study of uncertainties in physical measurements. 2nd Ed (1997), University Science Books, Sausalito
44. Valle A.M., Radić Z., Rana B.K., Whitfield J.B., O'Connor D.T., Martin N.G., and Taylor P. The cholinesterases: analysis by pharmacogenomics in man. Chem. Biol. Interac. 25 (2008) 343-345
45. Vellom D., Radić Z., Li Y., Pickering N.A., Camp S., and Taylor P. Amino acid residues controlling acetylcholinesterase and butyrylcholinesterase specificity. Biochemistry 32 (1993) 12-17